Inno-Gene SA
WSE:IGN

Watchlist Manager

Inno-Gene SA

WSE:IGN

Watchlist

Dividends

Discount Rate

Price: 5.04 PLN -0.4% Market Closed

Market Cap: 17.7m PLN

Have any thoughts about
Inno-Gene SA?

Write Note

Write Note Create Alert Ask AI

Add Note Why Create Notes?

Capture your thoughts

Note Buy Sell Hold Pass

US	Johnson & Johnson NYSE:JNJ	Pharmaceuticals
US	Estee Lauder Companies Inc NYSE:EL	Consumer products
US	Exxon Mobil Corp NYSE:XOM	Energy
US	Church & Dwight Co Inc NYSE:CHD	Consumer products
US	Pfizer Inc NYSE:PFE	Pharmaceuticals
US	American Express Co NYSE:AXP	Financial Services
US	Nike Inc NYSE:NKE	Textiles, Apparel & Luxury Goods
US	Visa Inc NYSE:V	Technology
CN	Alibaba Group Holding Ltd NYSE:BABA	Retail
US	3M Co NYSE:MMM	Industrial Conglomerates
US	JPMorgan Chase & Co NYSE:JPM	Banking
US	Coca-Cola Co NYSE:KO	Beverages
US	Target Corp NYSE:TGT	Retail
US	Walt Disney Co NYSE:DIS	Media
US	Mueller Industries Inc NYSE:MLI	Machinery
US	PayPal Holdings Inc NASDAQ:PYPL	Technology

Add Price Alert

Price Target:

Last Price: 5.04 PLN

We'll email you a reminder when the closing price reaches USD.

If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Peter Lynch

Track and Analyze Performance

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.

Continuous Learning and Adaptation

Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.

Boost Decision Confidence

With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.

Why create notes?

Back

Delete Note

Do you really want to delete this note?
This action cannot be undone.

Remove price alert for reaching

Delete

Cancel

IGN Alert

Inno-Gene SA

5.04

-0.02 (-0.4%)

52 Week Range	N/A N/A
Price Target

We'll email you a reminder when the closing price reaches PLN.

Save Alert

Choose the stock you wish to monitor with a price alert.

	Johnson & Johnson NYSE:JNJ	US
	Estee Lauder Companies Inc NYSE:EL	US
	Exxon Mobil Corp NYSE:XOM	US
	Church & Dwight Co Inc NYSE:CHD	US
	Pfizer Inc NYSE:PFE	US
	American Express Co NYSE:AXP	US
	Nike Inc NYSE:NKE	US
	Visa Inc NYSE:V	US
	Alibaba Group Holding Ltd NYSE:BABA	CN
	3M Co NYSE:MMM	US
	JPMorgan Chase & Co NYSE:JPM	US
	Coca-Cola Co NYSE:KO	US
	Target Corp NYSE:TGT	US
	Walt Disney Co NYSE:DIS	US
	Mueller Industries Inc NYSE:MLI	US
	PayPal Holdings Inc NASDAQ:PYPL	US

Delete Alert

This alert will be permanently deleted.

Remove note

Delete

Cancel

Ask me anything about

Inno-Gene SA

What unique competitive advantages
does Inno-Gene SA hold over its rivals?

What risks and challenges
does Inno-Gene SA face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Provide an overview of the primary business activities
of Inno-Gene SA.

What unique competitive advantages
does Inno-Gene SA hold over its rivals?

What risks and challenges
does Inno-Gene SA face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Inno-Gene SA.

Provide P/S
for Inno-Gene SA.

Provide P/E
for Inno-Gene SA.

Provide P/OCF
for Inno-Gene SA.

Provide P/FCFE
for Inno-Gene SA.

Provide P/B
for Inno-Gene SA.

Provide EV/S
for Inno-Gene SA.

Provide EV/GP
for Inno-Gene SA.

Provide EV/EBITDA
for Inno-Gene SA.

Provide EV/EBIT
for Inno-Gene SA.

Provide EV/OCF
for Inno-Gene SA.

Provide EV/FCFF
for Inno-Gene SA.

Provide EV/IC
for Inno-Gene SA.

What are the Revenue projections
for Inno-Gene SA?

How accurate were the past Revenue estimates
for Inno-Gene SA?

What are the Net Income projections
for Inno-Gene SA?

How accurate were the past Net Income estimates
for Inno-Gene SA?

What are the EPS projections
for Inno-Gene SA?

How accurate were the past EPS estimates
for Inno-Gene SA?

What are the EBIT projections
for Inno-Gene SA?

How accurate were the past EBIT estimates
for Inno-Gene SA?

Compare the revenue forecasts
for Inno-Gene SA with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Inno-Gene SA and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Inno-Gene SA against its competitors.

Analyze the profit margins
(gross, operating, and net) of Inno-Gene SA compared to its peers.

Compare the P/E ratios
of Inno-Gene SA against its peers.

Discuss the investment returns and shareholder value creation
comparing Inno-Gene SA with its peers.

Analyze the financial leverage
of Inno-Gene SA compared to its main competitors.

Show all profitability ratios
for Inno-Gene SA.

Provide ROE
for Inno-Gene SA.

Provide ROA
for Inno-Gene SA.

Provide ROIC
for Inno-Gene SA.

Provide ROCE
for Inno-Gene SA.

Provide Gross Margin
for Inno-Gene SA.

Provide Operating Margin
for Inno-Gene SA.

Provide Net Margin
for Inno-Gene SA.

Provide FCF Margin
for Inno-Gene SA.

Show all solvency ratios
for Inno-Gene SA.

Provide D/E Ratio
for Inno-Gene SA.

Provide D/A Ratio
for Inno-Gene SA.

Provide Interest Coverage Ratio
for Inno-Gene SA.

Provide Altman Z-Score Ratio
for Inno-Gene SA.

Provide Quick Ratio
for Inno-Gene SA.

Provide Current Ratio
for Inno-Gene SA.

Provide Cash Ratio
for Inno-Gene SA.

What is the historical Revenue growth
over the last 5 years for Inno-Gene SA?

What is the historical Net Income growth
over the last 5 years for Inno-Gene SA?

What is the current Free Cash Flow
of Inno-Gene SA?

Discuss the annual earnings per share (EPS)
trend over the past five years for Inno-Gene SA.

P/S
Price to Sales

38.3

Current

1.1

Median

4.2

Industry

Higher than median

Higher than industry value

Price to Sales (P/S) ratio is a valuation multiple that compares a company’s market capitalization to its revenues. It is an indicator of the value that financial markets have placed on each dollar of a company’s sales.

P/S

38.3

Market Cap

17.7m PLN

Revenue

462k PLN

All Countries

Forward Multiples

			Market Cap	P/S
PL	I	Inno-Gene SA WSE:IGN	17.7m PLN	38.3
US	P	PerkinElmer Inc LSE:0KHE	1.3T USD	486.2
US		Thermo Fisher Scientific Inc NYSE:TMO	207B USD	4.9
US		Danaher Corp NYSE:DHR	174.4B USD	8.2
KR		Samsung Biologics Co Ltd KRX:207940	67.6T KRW	16.1
CH		Lonza Group AG SIX:LONN	40.2B CHF	6
US		IQVIA Holdings Inc NYSE:IQV	38.4B USD	2.5
US		Agilent Technologies Inc NYSE:A	38.6B USD	5.9
US		Mettler-Toledo International Inc NYSE:MTD	26.7B USD	7.1
US		West Pharmaceutical Services Inc NYSE:WST	24.9B USD	8.7
US		Illumina Inc NASDAQ:ILMN	23.3B USD	5.3

				Revenue Growth
PL	I	Inno-Gene SA WSE:IGN	Average P/S: 53.6 38.3	N/A
US	P	PerkinElmer Inc LSE:0KHE	486.2	16%
US		Thermo Fisher Scientific Inc NYSE:TMO	4.9	14%
US		Danaher Corp NYSE:DHR	8.2	14%
KR		Samsung Biologics Co Ltd KRX:207940	16.1	60%
CH		Lonza Group AG SIX:LONN	6	33%
US		IQVIA Holdings Inc NYSE:IQV	2.5	15%
US		Agilent Technologies Inc NYSE:A	5.9	8%
US		Mettler-Toledo International Inc NYSE:MTD	7.1	12%
US		West Pharmaceutical Services Inc NYSE:WST	8.7	14%
US		Illumina Inc NASDAQ:ILMN	5.3	7%

P/S Forward Multiples

Forward P/S multiple is a version of the P/S ratio that uses forecasted revenue for the P/S calculation. 1-Year, 2-Years, and 3-Years forwards use revenue forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward

P/S

N/A

2-Years Forward

P/S

N/A

3-Years Forward

P/S

N/A

Inno-Gene SA
WSE:IGN

P/S
Price to Sales

P/S Forward Multiples

See Also

Company

Help

Tools

Stocks

Inno-Gene SA WSE:IGN

P/S Price to Sales

P/S Forward Multiples

See Also

Company

Help

Tools

Stocks

Inno-Gene SA
WSE:IGN

P/S
Price to Sales